Literature DB >> 2690079

An altered v-raf is required in addition to v-myc in J3V1 virus for acceleration of murine plasmacytomagenesis.

J Troppmair1, M Potter, J S Wax, U R Rapp.   

Abstract

We have isolated and molecularly cloned a highly pathogenic virus variant, J3V1, from murine plasmacytomas induced by a combination of pristane and the weakly transforming recombinant retrovirus J3. J3 virus is a derivative of the v-raf/v-myc-carrying J2 virus that was generated by a frameshifting deletion inactivating v-raf in J2. J3V1 contains an additional deletion of 334 base paris in gag, which restores the correct reading frame for v-raf and results in the expression of a p57 gag-raf fusion protein. Reactivation of v-raf in J3 is required for efficient plasmacytoma acceleration in pristane-conditioned BALB/cAn mice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2690079      PMCID: PMC298618          DOI: 10.1073/pnas.86.24.9941

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Plasmacytomas in mice.

Authors:  M Potter
Journal:  Semin Oncol       Date:  1986-09       Impact factor: 4.929

2.  Plasmacytoma induction by J series of v-myc recombinant retroviruses: evidence for the requirement of two (raf and myc) oncogenes for transformation.

Authors:  J Troppmair; M Huleihel; J Cleveland; J F Mushinski; J Kurie; H C Morse; J S Wax; M Potter; U R Rapp
Journal:  Curr Top Microbiol Immunol       Date:  1988       Impact factor: 4.291

3.  Identification and characterization of c-raf phosphoproteins in transformed murine cells.

Authors:  A M Schultz; T Copeland; S Oroszlan; U R Rapp
Journal:  Oncogene       Date:  1988-02       Impact factor: 9.867

4.  Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor.

Authors:  D F Stern; A B Roberts; N S Roche; M B Sporn; R A Weinberg
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

5.  Recombinant murine retroviruses containing avian v-myc induce a wide spectrum of neoplasms in newborn mice.

Authors:  H C Morse; J W Hartley; T N Fredrickson; R A Yetter; C Majumdar; J L Cleveland; U R Rapp
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  Avian v-myc replaces chromosomal translocation in murine plasmacytomagenesis.

Authors:  M Potter; J F Mushinski; E B Mushinski; S Brust; J S Wax; F Wiener; M Babonits; U R Rapp; H C Morse
Journal:  Science       Date:  1987-02-13       Impact factor: 47.728

7.  Rapid induction of IgM-secreting murine plasmacytomas by pristane and an immunoglobulin heavy-chain promoter/enhancer-driven c-myc/v-Ha-ras retrovirus.

Authors:  R Clynes; J Wax; L W Stanton; S Smith-Gill; M Potter; K B Marcu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Rapid induction of hemopoietic neoplasms in newborn mice by a raf(mil)/myc recombinant murine retrovirus.

Authors:  U R Rapp; J L Cleveland; T N Fredrickson; K L Holmes; H C Morse; H W Jansen; T Patschinsky; K Bister
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

9.  Characterization of murine A-raf, a new oncogene related to the v-raf oncogene.

Authors:  M Huleihel; M Goldsborough; J Cleveland; M Gunnell; T Bonner; U R Rapp
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

10.  Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus.

Authors:  S Ohno; S Migita; F Wiener; M Babonits; G Klein; J F Mushinski; M Potter
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  7 in total

1.  Assessment of all-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasia.

Authors:  N Swaminathan; G Lopez-Berestein; S Rudikoff
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

2.  Establishment and characterization of lymphoid and myeloid mixed-cell populations from mouse late embryoid bodies, "embryonic-stem-cell fetuses".

Authors:  U Chen; M Kosco; U Staerz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

3.  Induction of plasmacytomas secreting antigen-specific monoclonal antibodies with a retrovirus expressing v-abl and c-myc.

Authors:  E M Weissinger; H Mischak; D A Largaespada; D A Kaehler; T Mitchell; S J Smith-Gill; R Risser; J F Mushinski
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

4.  T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors.

Authors:  D M Hilbert; M Y Shen; U R Rapp; S Rudikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

5.  An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.

Authors:  H Rosenbaum; A W Harris; M L Bath; J McNeall; E Webb; J M Adams; S Cory
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

6.  Interleukin 6 is essential for in vivo development of B lineage neoplasms.

Authors:  D M Hilbert; M Kopf; B A Mock; G Köhler; S Rudikoff
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

7.  Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.

Authors:  Eun Sung Park; John D Shaughnessy; Shalu Gupta; Hongyang Wang; Ju-Seog Lee; Hyun Goo Woo; Fenghuang Zhan; James D Owens; Michael Potter; Siegfried Janz; J Frederic Mushinski
Journal:  BMC Genomics       Date:  2007-08-31       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.